Does Dual Therapy Hasten Antidepressant Response?

PHASE4CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

March 31, 2012

Conditions
Major Depressive Disorder
Interventions
DRUG

escitalopram

10mg/d increasing by 10 mg/week to a maximum of 40 mg/d if tolerated and not remitted

DRUG

bupropion extra long (XL)

150mg/d increasing to 300 mg/d after 1 week and 450 mg/d after 3 weeks, all increases if tolerated and not remitted

DRUG

escitalopram + bupropion

same dosing schedule as for monotherapy

Trial Locations (2)

10032

New York State Psychiatric Institute, New York

K1Z7K4

University of Ottawa, Institute of Mental Health Research, Ottawa

All Listed Sponsors
collaborator

University of Ottawa

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00519428 - Does Dual Therapy Hasten Antidepressant Response? | Biotech Hunter | Biotech Hunter